"Triple Negative Adult B-cell Acute Lymphoblastic Leukemia - TRINEG-ALL"

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Leukemia, Lymphoblastic
Interventions
OTHER

"Triple negative adul B-cell ALL"

"Samples will be studied with conventional techniques to classify and define properly the disease: morphology, immunophenotype, immunohistochemistry (IHC), conventional Cytogenetic Fluorescence in Situ Hybridization (FISH) will be used when appropriate.~● Isolation of Mononuclear cells~The following research methodologies will be applied:~* Next Generation Sequencing~* Flow cytometry analysis of 3C-up B-ALL top three markers~* Gene expression profile analysis~* Copy number Alterations analysis~* In vitro studies"

Trial Locations (3)

47014

RECRUITING

Irst Irccs, Meldola

47923

RECRUITING

Ospedale Infermi, Rimini

48121

RECRUITING

Ospedale S. Maria delle Croci RAVENNA, Ravenna

All Listed Sponsors
lead

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

OTHER